Clinical Psychopharmacology is a specialized field at the intersection of psychiatry and pharmacology, devoted to understanding the effects of psychotropic medications on mental health. This discipline plays a pivotal role in the treatment of various psychiatric disorders, offering interventions that target neurotransmitter systems to alleviate symptoms. Practitioners in clinical psychopharmacology utilize evidence-based approaches to prescribe and monitor the use of psychotropic drugs, tailoring treatments to individual patient needs. The field encompasses the study of a wide range of medications, including antidepressants, antipsychotics, anxiolytics, and mood stabilizers. Monitoring side effects and adjusting medication regimens based on individual responses are critical aspects of clinical psychopharmacology. Ethical considerations, informed consent, and a comprehensive understanding of psychopathology are integral to responsible practice in this field. The evolving landscape of neuroscience and pharmacology continually informs clinical psychopharmacology, allowing for the development of novel medications and personalized treatment approaches. Collaboration between mental health professionals, pharmacologists, and researchers is essential for advancing the field and improving outcomes for individuals grappling with mental health challenges.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada